Phosphatidyllamivudine
Latest Information Update: 21 Jul 1998
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 21 Jul 1998 No-Development-Reported for Hepatitis B in USA (Unknown route)
- 18 Dec 1995 New profile
- 18 Dec 1995 Preclinical development for Hepatitis B in USA (Unknown route)